New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
Emmanuel J Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, posted on LinkedIn:
”Latest publication from the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital.
Highlights the variability in solid-phase antiphospholipid antibody (aPL) test results on different testing platforms.
Also highlights the decreasing use of ELISA-based procedures, and the disconnection between classification criteria for antiphospholipid syndrome (APS), as used for research, versus diagnostic criteria (see also here).
The latest publication is available for free download for the next 50 days using this link.”
Title: A contemporary analysis of solid-phase antiphospholipid antibody testing: implications for classification or diagnosis of antiphospholipid syndrome
Authors: Caitlin Thirunavukarasu, Leonardo Pasalic, Emmanuel J. Favaloro
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?